The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The BSE has received a disclosure under Regulation 29(2) of the SEBI Takeover Regulations from Arjan Lalchandani, who is associated with Dr Lalchandani Labs Ltd. This regulation requires persons holding more than 5% of a company's shares to disclose any acquisition or disposal of shares. The specific details of the transaction — whether it is a buy or sell, the number of shares involved, and the resulting shareholding — are not provided in the headline. Without the detailed disclosure data, the direction and scale of the change in stake cannot be determined from the available information.
Investors should look for the detailed disclosure to understand whether the promoter is increasing or reducing their stake, as this can be a signal of promoter confidence or a need to monetize holdings. The stock may see minor short-term sentiment impact once the transaction details are made public.